IgE as a predictor to omalizumab response in patients with chronic spontaneous urticaria by Luis Felipe Ensina, Larissa Brandão, Luisa Karla Arruda, Faradiba Sarquis Serpa, Régis Albuquerque Campos, Solange Rodrigues Oliveira Valle, Paulo Ricardo Criado, Sarbjit Singh Saini, Roberta Fachini Jardim Criado

Subjects: Get full text

The Significance of Eosinophil-to-Lymphocyte Ratio in Predicting Response to Omalizumab Treatment in Patients with Bullous Pemphigoid: A Case Series by Gülfem Akin, Ceylan Avci, Sevgi Akarsu

Subjects: Get full text

Case report: Advanced age at transplantation and pre-emptive treatment with dupilumab in DOCK8 deficiency by Sophia Trombello, Sophia Trombello, Andrea Jarisch, Andre Willasch, Eva Rettinger, Julia Fekadu-Siebald, Dirk Holzinger, Dirk Holzinger, Roland Adelmann, Peter Bader, Shahrzad Bakhtiar

Subjects: Get full text

Rapid food desensitization associated with omalizumab before oral immunotherapy by Bruna Giavina-Bianchi, MD, Pedro Giavina-Bianchi, MD, PhD

Subjects: Get full text

Efficacy of hydroxychloroquine and omalizumab in a patient with systemic lupus erythematosus, Hashimoto thyroiditis and refractory chronic spontaneous urticaria by Öner Özdemir, Ümmügülsüm Dikici, Sena Sultan Karaca

Subjects: Get full text

Residue-resolved insights into the stabilization of therapeutic proteins by excipients: A case study of two monoclonal antibodies with arginine and glutamate by Tobias M. Prass, Patrick Garidel, Lars V. Schäfer, Michaela Blech

Subjects: Get full text